miLab

The miLab platform is an innovative POCT hematology system combining a compact analyzer with disposable cartridges for automated blood cell morphology analysis (BCMA). Its hydrogel-based stamping technology enables solution-free blood cell staining and imaging, eliminating the need for reagents or manual preparation. Studies have highlighted its potential in infectious disease contexts such as COVID-19, where blood cell morphology can inform treatment and prognosis. With quick training, simple operation, and cartridge-based workflow, miLab is positioned as a near-patient digital morphology solution for clinics, emergency settings, and decentralized labs.

For more info: Download Datasheet

System Concept

• miLab is a point-of-care diagnostic platform built around miLab Device + miLab Cartridge, designed for automated Blood Cell Morphology Analysis (BCMA).
  

• Uses hydrogel-based stamping technology for solution-free blood cell staining, enabling rapid and reagent-free slide preparation.
  

Technology & Principles

• BCMA (Blood Cell Morphology Analysis): digital morphology analysis directly from whole blood.
  

• Automated cartridge-based workflow (sample-in, result-out).
  

• Hydrogel-stamping allows visualization of blood cell structures without additional reagents.
  

• Integrates optical imaging with AI-based analysis for morphology classification.
  

Applications

• Hematology: near-patient morphology assessment of WBC, RBC, platelets.
  

• COVID-19 Prognosis: referenced in clinical studies as BCMA morphology changes can help guide prognostication and treatment of COVID-19 patients.
  

• Broad clinical settings: emergency care, infectious disease management, hematology follow-up.
  

Workflow

• Uses a disposable miLab Cartridge for sample handling.
  

• No need for chemical stains or wet reagents.
  

• Compatible with whole blood samples.
  

• Designed for rapid, low-maintenance operation with minimal user steps.
  

Supporting Evidence

• Reference video materials:
  

• Quick user guide (2 mins)
  

• Training video on device + cartridge usage (12 mins)
  

• Reference publication:Hydrogel-Based Stamping Technology for Solution-Free Blood Cell Staining (validating the core staining-free imaging approach).
  

• Reference thesis/publication: Demonstrates BCMA’s utility in guiding treatment decisions for COVID-19 patients.
  

Advantages

• Portable & simple → suitable for bedside and decentralized testing.
  

• Eliminates chemical staining → safer, cleaner, and faster workflow.
  

• Cartridge-based, no cross-contamination.
  

• AI + imaging supports objective morphology reporting.